Abstract A067: [Advocate Abstract] Making strides against a rare disease: Renal medullary carcinoma

Abstract

Abstract Making Strides Against a Rare Disease: Renal Medullary Carcinoma (RMC) seeks to provide an overview of an extremely rare cancer that was first described as a novel form of renal malignancy in a series published by Colonel Davis of the Armed Forces Institute of Pathology in 1995. This study was based upon retrospective analysis of tumors coded as renal pelvic carcinoma from patients aged less than 40 years. Where race had been recorded, all patients were black and all had sickled erythrocytes on histologic examination. On this basis the tumor, which was termed medullary carcinoma on morphologic grounds, was designated the seventh sickle cell nephropathy. Citation Format: Michael B. Lawing. [Advocate Abstract] Making strides against a rare disease: Renal medullary carcinoma [abstract]. In: Proceedings of the Eleventh AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2018 Nov 2-5; New Orleans, LA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2020;29(6 Suppl):Abstract nr A067.